Se ha denunciado esta presentación.
Se está descargando tu SlideShare. ×
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Anuncio
Cargando en…3
×

Eche un vistazo a continuación

1 de 30 Anuncio

Más Contenido Relacionado

Similares a product-review.ppt (20)

Más reciente (20)

Anuncio

product-review.ppt

  1. 1. 0 Right First Time Six Sigma Project “Improve batch record system for Packaging ” Start Date: 01 Feb 2008 Black Belt: Marina Suryanto Sponsor: Sis Mardini (QO Manager) Process Owner: Raharsih Basrodin (Production) Team Members: Production: Lily, Yaseph, Lely QA: S. Wigati, Yodi, Melissa I-nexus ID: 3,031
  2. 2. 1 Control Improve Analyze Measure Define The lead time to manufacture to release is too long. Problem Statement Business Case Expected business results: • Reliable supply of product • Improve quality of records • Reduce time and efforts needed to complete batch documentation
  3. 3. 2 Scope Control Improve Analyze Measure Define The lead time to manufacture comprises of 2 parts i.e: 1. Raw material receipt to bulk film coated tablet and final blend release (Project INX 7724 by JTM) 2. Primary packaging to product disposition Product : Ponstan 500 mg Film Coated Tablet (FCT) and Terramycin (TM) Oph. Oint. START : Ponstan  Blistering TM  Filling ointment STOP : Product disposition by QA Exclude : Batch with deviation and validation
  4. 4. 3 Project Goal PROJECT GOAL METRIC BASELINE* CURRENT GOAL Reduction of packaging lead time (LT) Working Days Ponstan I: Average 53 TM Oph II: Average 26 TBD Ponstan*: Max 20 days/ batch TM Oph*: Max 25 days/ batch Control Improve Analyze Measure Define I Data collected from lot released in Jul 2007 to Jan 2008. II Data collected from lot released in Feb 2007 to Feb 2008 * Maximum exclude validation batch and deviation
  5. 5. 4 Control Improve Analyze Measure Define Process Map Packaging Flow of Ponstan 500 mg FCT (As Is) Pack into Multicarton Released coated tablets Pack into Shipper Folding Leaflet Printing Multicarton Folded leaflet Printed multicarton B Yes No Blistering Inspection on defects Export product? Pack into Export shipper
  6. 6. 5 Control Improve Analyze Measure Define Process Map Batch Record Process of Ponstan 500 mg FCT (As Is) TL calculate product yield & accountability B TL Completion in MAPS by TL Prod. Admin review batch record for doc. error Yes Admin Prod Spv Ok? No TL/ Operator/ Inspector Record data in the log book of doc error Prod Spv review and sign off the batch record Prod Manager Prod Manager review and sign-off the batch record Ok? Yes Yes No QA Spv review and sign-off the batch record Quality Assurance Profiles (QAP) Ok? Yes Disposition in MAPS Ok? Yes Create CoA QA Manager review and sign-off the batch record Ok? No Prod Manager/ Inspector/ Lab Manager No Prod. Manager/ QA Spv QA Spv QA Manager Review Batch record = Manufacturing + Packaging batch record
  7. 7. 6 Control Improve Analyze Measure Define Process Map Packaging Flow of TM Oph. Oint. (As Is) Final blend Sampling for Lab Test Testing Gamma radiation Irradiated products Cartoning A Folding Leaflet Printing Multicarton Folded leaflet Printed multicarton Packing for Gamma radiation Inspection on defect Yes Inspection on defect Filling Market: Korea? Pack into Shipper No Pack into Multicarton Shrink wrapping Testing Sampling for Micro Test Pack into Shipper
  8. 8. 7 Control Improve Analyze Measure Define Process Map Batch Record Process of TM Oph. Oint. (As Is) Review Batch record = Manufacturing + Packaging batch record TL calculate product yield & accountability B TL Completion in MAPS by TL Yes Admin Prod Spv Ok? No TL/ Operator/ Inspector Record data in the log book of doc error Prod. Admin review batch record for doc. error Prod Manager Prod Manager review and sign-off the batch record Ok? Yes Yes No QA Spv review and sign-off the batch record Quality Assurance Profiles (QAP) Ok? Yes Disposition in MAPS Ok? Yes Create CoA QA Manager review and sign-off the batch record Ok? No Prod Manager/ Inspector/ Lab Manager No Prod. Manager/ QA Spv QA Spv QA Manager Prod Spv review and sign off the batch record
  9. 9. 8 Control Improve Analyze Measure Define DATA PLOT PONSTAN 500 MG FCT Total manufacturing lead time ranges from 59 to 99 days with median of 77 days. Production process LT ranges from 17 to 37 days with median of 25 days. Packaging to disposition LT ranges from 38 to 77 days with average of 52 days which contributes 68% to the total LT. Total Manufacturing LT = Production LT + Packaging to disposition LT 729-30164 729-30158 729-30152 729-30146 729-30137 729-30129 729-30123 729-30112 729-30099 729-30045 729-30038 100 90 80 70 60 50 40 30 20 10 Lot No Days Med: 25 Avg: 52 Med: 77 Production LT Packaging LT Total Manufacturing LT Variable Time Series Plot of Production LT, Packaging LT, and Total Manufacturing LT
  10. 10. 9 Control Improve Analyze Measure Define DATA PLOT PONSTAN 500 MG FCT 729-30164 729-30158 729-30152 729-30146 729-30137 729-30129 729-30123 729-30112 729-30099 729-30045 729-30038 80 70 60 50 40 30 20 10 0 Lot No Lead Time (Working Days) Med: 2 Avg: 50 Avg: 53 Packaging Lead Time Final Review Lead Time Total LT (Pack-Disposition) Variable Time Series Plot of Packaging, Final Review, and Total LT (Pack - Disposition) Total lead time ranges from 38 to 77 days with average of 53 days. Packaging process LT ranges from 1 to 12 days with median of 2 days. Final review LT ranges from 35 to 75 days with average of 50 days which contributes 94% to the total LT. LT (Pack – Disposition) = Packaging LT + Final review LT
  11. 11. 10 Control Improve Analyze Measure Define DATA PLOT PONSTAN 500 MG FCT 79% of the total review LT is contributed by the production review time. Production review LT ranges from 26 – 58 days with average of 39 days. QA review LT ranges from 1 – 28 days with average of 10 days. Total Final Review LT QA Review LT Production Review LT 80 70 60 50 40 30 20 10 0 Days 38.8333 10.4833 49.5 Boxplot of Production Review LT and QA Review LT
  12. 12. 11 Control Improve Analyze Measure Define DATA PLOT TM Oph. Oint. Total Manufacturing LT = Production LT + Packaging to disposition LT 8-52001 7-52050 7-52042 7-52034 7-52030 7-52026 7-52023 7-52020 7-52010 7-52005 50 40 30 20 10 0 Lot No Days Med: 3 Avg: 27 Avg: 30 Production LT Packaging LT Total Manufacturing LT Variable Time Series Plot of Production LT, Packaging LT, Total Manufacturing LT Total manufacturing lead time ranges from 2 to 7 days with average of 30 days. Production process LT ranges from 14 to 45 days with median of 3 days. Packaging to disposition LT ranges from 17 to 48 days with average of 27 days which contributes 90% to the total LT.
  13. 13. 12 Control Improve Analyze Measure Define DATA PLOT TM Oph. Oint. Total LT ranges from 14 to 45 days with average of 26 days. Packaging LT ranges from 6 to 21 days with median of 10 days. Final review lead time ranges from 5 to 30 days with average of 16 days which contributes 62% to the total LT. 8-52001 7-52050 7-52042 7-52034 7-52030 7-52026 7-52023 7-52020 7-52010 7-52005 50 40 30 20 10 0 Lot No Lead Time (Working Days) Avg: 26 Avg: 16 Med: 10 Packaging LT_1 Final Rev iew LT_1 Total LT (Pack - Disposition)_1 V ariable Time Series Plot of Packaging, Final Review, and Total LT (Pack - Disposition) LT (Pack – Disposition) = Packaging LT + Final review LT
  14. 14. 13 Control Improve Analyze Measure Define DATA PLOT TM Oph. Oint. Production review time ranges from 1 – 18 days with average of 8 days. QA review lead time ranges from 1 – 25 days with average of 8 days. Total Final Review LT QA Review LT Production Review LT 30 25 20 15 10 5 0 Days 7.84375 8.125 16.0938 Boxplot of Production Review LT and QA Review LT
  15. 15. CAPABILITY ANALYSIS 14 Control Improve Analyze Measure Define 100% of the batches cannot meet the lead time of max 20 days. Data is approx. normal 70 60 50 40 30 20 USL LSL * Target * USL 20 Sample Mean 52.3 Sample N 60 StDev (O v erall) 6.89461 Process Data Pp * PPL * PPU -1.56 Ppk -1.56 C pm * O v erall C apability % < LSL * % > USL 100.00 % Total 100.00 O bserv ed Performance % < LSL * % > USL 100.00 % Total 100.00 Exp. O v erall Performance Process Capability of Packaging Lead Time of Ponstan 500 mg FCT
  16. 16. CAPABILITY ANALYSIS 15 Control Improve Analyze Measure Define 40 32 24 16 8 USL LSL * Target * USL 25 Sample Mean 26.6875 Sample N 32 StDev (O v erall) 8.05801 Process Data Pp * PPL * PPU -0.07 Ppk -0.07 C pm * O v erall C apability % < LSL * % > USL 50.00 % Total 50.00 O bserv ed Performance % < LSL * % > USL 58.29 % Total 58.29 Exp. O v erall Performance Process Capability of Packaging Lead Time of TM Oph Oint 58% of the batches cannot meet the lead time of max 25 days. Data is approx. normal
  17. 17. 16 Value Stream Map Analysis (Ponstan 500 mg FCT) Control Improve Analyze Measure Define Total Packaging Lead Time ranges from 24 – 29 days. Total processing time (P/T) ranges from 3 – 3.5 days (23 – 26 hours) Total delay time ranges from 21 – 26 days. Delay time was 89% of total LT Processing time in batch record review ranges from 6 – 8 hours per batch with delay time 19 - 24 days. Delay time in review process needs to be minimized. Note: Data taken from measurement of 3 batches Printing Multicarton Folding Leaflet Blistering Completion by TL Review by Production Secondary Packing I I I I I Review & Disposition by QA Warehouse Production - Process Warehouse PT: 8 – 9 hours LT: 1 WD PT: 6 – 8 hours LT: 1 WD PT: 0.5 hours LT: 1 WD PT: 4 – 7 hours LT: 17 - 21 WD PT: 1 – 2 hours LT: 2 - 3 WD PT: 1.5 - 2 hours PT: 0.5 hours 0 WD 0 0 – 1 WD 2 WD 1 - 4 WD
  18. 18. 17 Value Stream Map Analysis (TM Oph Oint) Control Improve Analyze Measure Define Total Packaging Lead Time ranges from 22 - 33 days. Total processing time (P/T) ranges from 15 – 18 days (113 – 134 hours ) Total delay time ranges from 6 - 15 days (45 – 113 hours). Delay time was 37% of total LT. Processing time in batch record review ranges from 7 – 10 hours per batch with delay time 2 – 10 working days. Delay time in review process needs to be minimized. Note: Data taken from measurement of 3 batches Filling & Packing for Radiation 8 I Gamma Radiation Printing carton 2 Completion by TL 1 Review by Production 3 Secondary Packing 8 I I I I I Review & Disposition by QA 2 PT: 22.5 – 25 hours PT: 2 – 3 WD Lab Testing (Chem&Micro) 5 Production - Process Warehouse Lab Testing (Chemical) 2 Folding Leaflet 1 0 - 2 1 - 2 Inspection on defects 6 I I PT: 2 WD 0 PT: 4 - 5 WD 1 - 2 PT: 3.5 – 6 WH 0 - 5 PT: 6 - 9 WH 0 - 1 PT: 1.5 WH LT: 3 WD LT: 3 - 4 WD LT: 5 – 6 WD LT: 2 – 5 WD LT: 4 – 5 WD LT: 1 - 2 WD LT: 1 - 8 WD PT: 7.5 – 8.5 hours LT: 1 - 2 WD PT: 4.5 – 7 hours LT: 2 WD Warehouse PT: 2 hours PT: 14.3 hours
  19. 19. 18 Brainstorming Why batch record review lead time is too long? 1. Structure and content of batch record is not user friendly/ complicated 2. Effort and time needed for correcting documentation errors 3. Flow of batch record review process is not efficient. Review level that is labor intensive involving several personnel. The overall documents of the batch record from manufacturing to packaging is reviewed at the end of the process. 4. Standard lead time for batch record review and product release is not clearly defined. Delay time during final review is high. 5. Batch record is accumulated waiting for review and sent to QA including waiting time for approved QAP for TM Oph. Oint. Control Improve Analyze Measure Define
  20. 20. 19 Batch record is accumulated waiting for review and sent to QA Numbers of Batch Record sent to QA per month was variable ranges from 1 – 23 batch records per receiving day with median of 5/ day. Control Improve Analyze Measure Define 23-May-08 7-May-08 21-Apr-08 9-Apr-08 26-M ar-08 10-M ar-08 21-Feb-08 11-Feb-08 17-Jan-08 3-Jan-08 25 20 15 10 5 0 Date No of Batch Records Med=5 Time Series Plot of No of Batch Records to QA per day
  21. 21. 20 Waiting time for QAP Availability The QA review lead time, which ranges from 1 – 25 days, includes the waiting lead time for QAP from lab. QAP LT ranges from -19 to 11 days. Minus value means that the QAP has been received prior to the batch records sent to QA. 8-52004 7-52056 7-52049 7-52035 7-52031 7-52028 (MA L) 7-52024 7-52021 7-52010 7-52005 30 20 10 0 -10 -20 Lot No Days QAP LT QA review LT Variable Time Series Plot of QAP LT & QA Review LT QAP LT = Batch record receive date – QAP receive date Control Improve Analyze Measure Define
  22. 22. 21 Improvement Matrix Control Improve Analyze Measure Define Potential X’s Proposed Solution Supporting Data Structure and content of batch record is not user friendly/ complicated: Excessive data entries, excessive signatures, Many separate forms are linked to the batch record for data recording. Excessive data verification during IPC between Production and QA Re-structure of batch record both contents and format. The content is also analyzed and some improvements are made to comply with PQS & regulatory requirements. Some of IPC activities and data verification will be transferred from QA to Production as per risk assessment. QA Risk assessment: New IPC matrix: Numbers of signatures for the new format of batch packaging records are reduced by approx. 50% (Ponstan FCT: 52%; TM Oph: 58%)
  23. 23. 22 Improvement Matrix Control Improve Analyze Measure Define Potential X’s Proposed Solution Supporting Data Documentation error - Re-structure batch record as above. - Training Operator on documentation practice for the new batch record - Flow of batch record review process is not efficient. Review level that is labor intensive involving several personnel. The overall documents of the batch record from manufacturing to packaging is reviewed at the end of the process New flow of packaging process including IPC and batch record review process: - Batch record will be reviewed at each defined stage. - Reviewers include Prod Spv, Prod Manager, QA Spv, QA Manager  Delete non-value-added activity i.e., Prod Admin function to check and record doc error. These functions will be integrated to all reviewers. See proposal of new flow in the next slides.
  24. 24. 23 Improvement Matrix Control Improve Analyze Measure Define Potential X’s Proposed Solution Supporting Data Waiting time for approved QAP of TM Oph Oint The Lab Spv will also sign off the batch record at each stage (Before radiation & after radiation) to confirm whether the test result meet or doesn’t meet spec. The QAP will be inserted into the batch record after the Lab Spv sign off the BR at the after radiation stage, then the batch record will be circulated to the Prod and QA Manager for final approval. This avoid the delay due to QAP documentation. - Batch record is accumulated waiting for review and sent to QA. Define standard lead time for review: 1) Review at each stage: Max 1 business day per reviewer per batch. 2) Final review: : Max 2 business day per reviewer per batch. - Standard lead time for batch record review and product release is not clearly defined. Delay time during final review is high.
  25. 25. 24 Proposal for New Process Flow Off-Line Printing Printing Examination & approval of printed multicarton sample Verification by QA Inspector PM Reconciliation Printing Inspection Review dan approval printing process by Prod Spv Batch packaging records – Printing stage Warehouse Packaging Line clearance Printed Multicarton Multicarton Control Improve Analyze Measure Define
  26. 26. 25 Proposal for New Process Flow Folding Leaflet Control Improve Analyze Measure Define Folding Examination & approval of folded leaflet sample PM reconciliation Review dan approval folding process by Prod Spv Batch packaging records – Folding stage Warehouse Packaging Line clearance Folded leaflet Leaflet
  27. 27. 26 Proposal for New Process Flow Filling & Packaging of TM Oph Oint 3.5 g Korea Control Improve Analyze Measure Define Final blend Compounding Line Clearance Filling Packing for radiation Inspection on defect of filled alutubes Gamma Radiation Radiated products Inspection on defect Packing into carton Packing into Multicarton Shrink wrapping Packing into export shipper Finished Products PPIC I Examination & approval of sample of embossed empty tube Verification by QA Inspector Start-Up Inspection on filled weight, foreign matter, blend homogeneity, and leak test Inspection on embossed lot no & exp date End of Run Check Inspection on defects Sampling Lab Testing (Chemical) Folded leaflet Printed Multicarton Sampling Lab Testing (Chemical & Micro) Reconciliation Batch record review & disposition Batch record review and approval (Filling stage) A B Examination & approval of embossed carton Inspection on embossed lot no & exp date Start up (30 carton) End of Run Check (30 carton) Weight monitoring of carton, multicarton, shipper Verification by QA Inspector Inspection on cartoning results Examination & approval of shipper label Inspection on product & packaging defects (ROI)
  28. 28. 27 Proposal for New Process Flow TM Oph Oint 3.5 g Batch Record Review Process Control Improve Analyze Measure Define Yes A Ok? Prod Spv TL/ Operator/ Inspector No Prod. Spv review and sign-off the batch record Lab Spv Lab Spv sign off the batch record QA Spv Ok? Yes Prod Spv No Approved batch packaging record (filling stage) QA Spv review and sign-off the batch record Yes B Ok? Prod Spv TL/ Operator/ Inspector No Prod. Spv review and sign-off the batch record Lab Spv Lab Spv sign off the batch record Ok? Yes Prod Spv No Completion in MAPS TL/ Prod Spv Production Manager review and sign-off the batch record QA Manager review and sign off the batch record Ok? Prod Manager QA Manager Approved batch packaging record Yes No Prod Manager Disposition in MAPS
  29. 29. 28 Proposal for New Process Flow Blistering & Packaging of Ponstan 500 mg FCT Control Improve Analyze Measure Define Coated Tablet Coating Line Clearance Blistering Finished Products PPIC Examination & approval of sample of embossed empty blister Verification by QA Inspector Leak Test Inspection on embossed lot no and exp date Inspection on blister defects Printed Multicarton Batch record review and disposition Packing into multicarton Packing into export shipper Reconciliation Examination & approval of shipper label Folded leaflet Inspection on product and packing defect (ROI) End of Run Check Weight monitoring of multicarton Start-Up A
  30. 30. 29 Proposal for New Process Flow Ponstan 500 mg FCT Batch Record Review Process Control Improve Analyze Measure Define Yes A Ok? Prod Spv TL/ Operator/ Inspector No Prod. Spv review and sign-off the batch record Ok? Yes Prod Spv No Completion in MAPS TL/ Prod Spv QA Manager review and sign off the batch record Ok? Prod Manager QA Manager Approved batch packaging record Yes No Prod Manager Disposition in MAPS Production Manager review and sign-off the batch record

Notas del editor

  • 0
  • 1

×